Suresh Durgam

Company: Intra-Cellular Therapies

Job title: Chief Medical Officer, Executive Vice President

Seminars:

Navigating Heterogeneity in Generalized Anxiety Disorder to Successfully Develop a Subtype-Selective Monotherapy Treatment 1:45 pm

Dealing with comorbidities and overlapping indications when recruiting an appropriate clinical population Determining which patients will be most responsive to a given anxiolytic therapy Accounting for fluctuations in anxiety levels in individual patients throughout the trialRead more

day: Day One Track B PM

Panel Discussion: Overcoming the Phase II/III Roadblock: Reflecting on Lessons Learned to Drive Novel Mechanisms of Action Through Clinical Trials & Beyond 9:00 am

What can we learn from successful pathways like Cobenfy to improve the success rate of phase II and III trials investigating new mechanisms? How can we mitigate the impact of high placebo response rates on clinical readouts? How did blinded data analytics feed into the results? What are the issues being encountered with patient selection…Read more

day: Day One AM